Ritonavir-Saquinavir Dual Protease Inhibitor Compared to Ritonavir Alone in Human Immunodeficiency Virus-Infected Patients

The objective of this study was to evaluate the antiretroviral efficacy and safety of ritonavir (600 mg twice a day [b.i.d.])-saquinavir (400 mg b.i.d.) compared to ritonavir (600 mg b.i.d.) in patients pretreated and receiving continued treatment with two nucleoside analogs. The study was placebo c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Michelet, Christian, Ruffault, Annick, Sébille, Véronique, Arvieux, Cedric, Jaccard, Philippe, Raffi, François, Bazin, Claude, Chapplain, Jean-Marc, Chauvin, Jean-Pierre, Dohin, Elisabeth, Cartier, François, Bellissant, Eric
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2001
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC90843/
https://ncbi.nlm.nih.gov/pubmed/11709314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.12.3393-3402.2001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados